跳至主導覽
跳至搜尋
跳過主要內容
長庚大學學術能量集萃 首頁
說明與常見問題
English
中文
首頁
學者概覽
研究單位
研究產出
研究計畫-專案
獎項
活動
新聞/媒體
按專業知識、姓名或所屬機構搜尋
Comparison of transdermal and oral estrogen-progestin replacement therapy: Effects on cardiovascular risk factors
Fang Ping Chen
*
, Ning Lee, Yung Kui Soong, Ko En Huang
*
此作品的通信作者
醫學系
Chang Gung Memorial Hospital
研究成果
:
期刊稿件
›
文章
›
同行評審
40
引文 斯高帕斯(Scopus)
總覽
指紋
指紋
深入研究「Comparison of transdermal and oral estrogen-progestin replacement therapy: Effects on cardiovascular risk factors」主題。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Therapy Effect
100%
Substitution Therapy
100%
Cardiovascular Risk
100%
Estrogen
100%
Gestagen
100%
Transdermal
100%
Therapeutic Procedure
75%
Lipid
75%
Hormone Substitution
75%
High Density Lipoprotein Cholesterol
75%
Triacylglycerol
50%
Cholesterol
50%
Hemostat
50%
Postmenopause
25%
Drug Therapy
25%
Transdermal Drug Administration
25%
Tissue Plasminogen Activator
25%
Plasminogen Activator Inhibitor-1
25%
Protein C
25%
Fibrinolysis
25%
Blood Clotting Factor
25%
Medroxyprogesterone Acetate
25%
Low-Density Lipoprotein
25%
Protein S
25%
Factor VII
25%
Low Density Lipoprotein Cholesterol
25%
Lipoprotein Metabolism
25%
Antithrombin III
25%
Antithrombin
25%
Valeric Acid
25%
Cyproterone Acetate
25%
Pharmacology, Toxicology and Pharmaceutical Science
Transdermal
100%
Replacement Therapy
100%
Estrogen
100%
Cardiovascular Risk
100%
Progestin
100%
Lipid
60%
Hormone
60%
High Density Lipoprotein Cholesterol
60%
Cholesterol
40%
Triacylglycerol
40%
Hemostatic Agent
40%
Lipoprotein
20%
Fibrinolytic Agent
20%
Tissue Plasminogen Activator
20%
Blood Clotting Factor
20%
Low Density Lipoprotein Cholesterol
20%
Medroxyprogesterone Acetate
20%
Low Density Lipoprotein
20%
Protein S
20%
Plasminogen Activator Inhibitor 1
20%
Protein C
20%
Cyproterone Acetate
20%
Valerate
20%
Antithrombin
20%
Antithrombin III
20%
Blood Clotting Factor 7
20%